Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Almut G Winterstein

Showing results (1-10 of 266) with videos related to

Pageof 27
Sort By:
Pharmacoepidemiology and Drug Safety|February 1, 2012
ADHD treatment--supply or demand?Almut G Winterstein
The Journal of Pediatric Pharmacology and Therapeutics : JPPT : the Official Journal of PPAG|June 19, 2025
Risk Management of Valproate and Other Teratogenic Anticonvulsants in the Era of Proliferating UseAlmut G Winterstein
Current Psychiatry Reports|August 6, 2013
Cardiovascular safety of stimulants in children: findings from recent population-based cohort studiesAlmut G Winterstein
Evidence-Based Mental Health|February 16, 2012
Use of ADHD drugs in children and young adults does not increase risk of serious cardiovascular adverse events compared with non-useAlmut G Winterstein
Addiction (Abingdon, England)|January 24, 2025
Re: The association between glucose-dependent insulinotropic polypeptide and/or glucagon-like peptide-1 receptor agonist prescriptions and substance-related outcomes in patients with opioid and alcohol use disorders: A real-world data analysisYanning Wang, Almut G Winterstein
JAMA|July 25, 2023
Ectopic Pregnancy Risk and Levonorgestrel-Releasing Intrauterine SystemsSebastian Jugl, Almut G Winterstein
Southern Medical Journal|March 28, 2008
Response to respiratory synctial virusChristian Hampp, Almut G Winterstein
Current Psychiatry Reports|June 12, 2012
Polypharmacy in attention deficit hyperactivity disorder treatment: current status, challenges and next stepsRegina Bussing, Almut G Winterstein
Journal of Clinical Medicine|July 11, 2019
Potential Adverse Drug Events and Drug-Drug Interactions with Medical and Consumer Cannabidiol (CBD) UseJoshua D Brown, Almut G Winterstein
American Journal of Obstetrics and Gynecology|August 6, 2023
Trade-offs in safety study design decisions on teratogenic gadolinium effectsAlmut G Winterstein, Sonja A Rasmussen
Pageof 27

Showing results (1-10 of 266) with videos related to

Sort By:
Pageof 27
Pharmacoepidemiology and Drug Safety|February 1, 2012
ADHD treatment--supply or demand?Almut G Winterstein
The Journal of Pediatric Pharmacology and Therapeutics : JPPT : the Official Journal of PPAG|June 19, 2025
Risk Management of Valproate and Other Teratogenic Anticonvulsants in the Era of Proliferating UseAlmut G Winterstein
Current Psychiatry Reports|August 6, 2013
Cardiovascular safety of stimulants in children: findings from recent population-based cohort studiesAlmut G Winterstein
Evidence-Based Mental Health|February 16, 2012
Use of ADHD drugs in children and young adults does not increase risk of serious cardiovascular adverse events compared with non-useAlmut G Winterstein
Addiction (Abingdon, England)|January 24, 2025
Re: The association between glucose-dependent insulinotropic polypeptide and/or glucagon-like peptide-1 receptor agonist prescriptions and substance-related outcomes in patients with opioid and alcohol use disorders: A real-world data analysisYanning Wang, Almut G Winterstein
JAMA|July 25, 2023
Ectopic Pregnancy Risk and Levonorgestrel-Releasing Intrauterine SystemsSebastian Jugl, Almut G Winterstein
Southern Medical Journal|March 28, 2008
Response to respiratory synctial virusChristian Hampp, Almut G Winterstein
Current Psychiatry Reports|June 12, 2012
Polypharmacy in attention deficit hyperactivity disorder treatment: current status, challenges and next stepsRegina Bussing, Almut G Winterstein
Journal of Clinical Medicine|July 11, 2019
Potential Adverse Drug Events and Drug-Drug Interactions with Medical and Consumer Cannabidiol (CBD) UseJoshua D Brown, Almut G Winterstein
American Journal of Obstetrics and Gynecology|August 6, 2023
Trade-offs in safety study design decisions on teratogenic gadolinium effectsAlmut G Winterstein, Sonja A Rasmussen
Pageof 27